Search

everythinglearnresearchcommunity

for

Search:↓

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

High afamin levels are linked to metabolic syndrome and may predict its development in women with insulin resistance.

Women with acne and irregular periods had higher active testosterone levels, which could suggest the usefulness of antiandrogen treatment.

Women with congenital adrenal hyperplasia (CAH) have more sexual function issues than those with polycystic ovary syndrome (PCOS), but physical activity can improve sexual functioning in all women.

Androgen replacement therapy can improve libido and mood in women with severe androgen deficiency, but more research is needed on its long-term safety.

The guidelines advise against using testosterone and DHEA in women for most conditions due to safety and effectiveness concerns, but suggest considering testosterone for postmenopausal women with low sexual desire.

Testosterone therapy can help women with androgen deficiency by improving energy, sex drive, and bone health with few side effects.

Chinese women with PCOS have higher androgen levels, which change with age and weight.

Different substances that activate or block the androgen receptor can affect male development and treat conditions like prostate cancer.

Vertex baldness has higher DHT levels than frontal baldness, but testosterone and PSA levels are similar.

Finasteride reduces dihydrotestosterone, increases testosterone, and may treat hirsutism in women.

Cytokines and neuropeptides are key in controlling androgen levels, affecting skin and hair conditions.

New method detects finasteride in plasma quickly and accurately without clean-up.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Ganoderma lucidum may help treat prostate cancer by blocking male hormones and slowing cancer cell growth.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

The conclusion is that standardizing testosterone measurement methods is essential for better diagnosis accuracy in women.

Androgens increase EPO production, finasteride doesn't significantly impact it.

Using two drugs together, Flutamide and 4-MA, is more effective for blocking male hormones than using each one alone.

Finasteride helps treat skin issues like acne and baldness by blocking testosterone conversion.

Different women's hair and skin glands respond to hormones in varied ways, which can cause unwanted hair growth even with normal hormone levels, and more research is needed to treat this effectively.

PRP injections increase hair density and satisfaction in androgenetic alopecia patients.

Finasteride affects brain and blood steroids, causing lasting sexual and emotional side effects.

The exact cause of increased 5α-reductase activity leading to hirsutism in women is still unknown.

Platelet-Rich Plasma (PRP), a substance from a patient's own blood, can stimulate hair regrowth in people with Androgenetic Alopecia (AGA) who haven't had success with other treatments, but more research is needed to optimize its use.

PRGF treatments increased hair number and thickness in people with hair loss, with more injections leading to better results.

Doctors used a special blood sampling technique to diagnose a woman's rare ovarian tumor that was producing male hormones.

Platelet-rich plasma injections are a cheap and effective way to reduce hair loss and improve hair quality in people with mild to moderate androgenetic alopecia.

A woman developed male traits from accidental contact with her husband's testosterone gel.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.